Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
79,764,587
-
Share change
-
+416,003
-
Total reported value
-
$11,861,468,865
-
Put/Call ratio
-
37%
-
Price per share
-
$148.96
-
Number of holders
-
347
-
Value change
-
+$65,047,101
-
Number of buys
-
174
-
Number of sells
-
146
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q4 2021
As of 31 Dec 2021,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
347 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,764,587 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, BAILLIE GIFFORD & CO, MORGAN STANLEY, ARK Investment Management LLC, 12 West Capital Management LP, Foresite Capital Management II, LLC, STATE STREET CORP, and SANDS CAPITAL MANAGEMENT, LLC.
This page lists
347
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.